Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan;29(1):182-184.
doi: 10.3350/cmh.2022.0411. Epub 2022 Nov 22.

Correspondence on Editorial regarding "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease"

Won Sohn  1 , Yong-Han Paik  2   3
Affiliations
Comment

Correspondence on Editorial regarding "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease"

Won Sohn et al. Clin Mol Hepatol. 2023 Jan.
No abstract available

Keywords: Chronic hepatitis; Early detection of cancer; Hepatocellular carcinoma; Liver cirrhosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Comment on

References

    1. Kim BH, Cho Y, Park JW. Surveillance for hepatocellular carcinoma: it is time to move forward. Clin Mol Hepatol. 2022;28:810–813. - PMC - PubMed
    1. Sohn W, Kang D, Kang M, Guallar E, Cho J, Paik YH. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease. Clin Mol Hepatol. 2022;28:851–863. - PMC - PubMed
    1. European Association for the Study of the Liver. European Association for the Study of the Liver EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. - PubMed
    1. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723–750. - PubMed
    1. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–1531. - PubMed

MeSH terms